You are here

NICE answers my questions about the MTA for dasatinib and nilotinib

to all those who are following this campaign please see the thread a little further down the page, started by Andy Parkin.

from the email i received today from NICE, there is still obviously a need to keep the pressure on the DH to give the go ahead to the MTA to take place... NICE cannot start until they have this....they only have a 'minded referall' so far...... so
for those of you who are willing to write letters then please, please do!
we need more that just two or three voices if we are to get the DH to listen.

thanks,
Sandy

i have heard that some PCT's in England have advised doctors that they should not consider putting patients on the ENACT (nilotinib)trials because they will NOT fund Tasigna.
the ENACT trials are still open and recruiting until April... HOWEVER there is a very small window of opportunity for patients showing resistance to Glivec NOW and who may be having problems with PCT/STA funding of dasatinib (Sprycel) BECAUSE Novartis has stated that in the UK situation they will provide continuation of the drug (nilotinib/Tasigna) for trial patients for 12 months after the trial closes pending NICE appraisal...

Sandy